Concord Biotech shares to list on Friday: Here is everything you need to know

Concord Biotech IPO, Concord Biotech IPO listing date: Global Biotechnology Company, Concord Biotech, is set to list its initial public offering (IPO) on Friday, August 18, 2023) on the BSE and the NSE.

Concord Biotech, which manufactures Active Pharmaceutical Ingredients (API) through fermentation and semi-synthetic processes and finished formulations, has an issue size of Rs 1,551 crore.

The price band for the share is Rs 705 to Rs 741. The IPO is a complete offer for sale where 2.09 crore shares are up for grabs. 

Zee Biz will tell you more key things about Concord Biotech IPO.

Important dates for Concord Biotech IPO 

The IPO of the company for subscription opened on Friday, August 4. The basis of the allotment of shares was finalised on August 11 (Friday). While successful bidders got shares credited to their dmat accounts on Thursday (August 17), the listing of the IPO is set to be done on Friday (August 18) on the BSE and the NSE.  

Concord Biotech IPO price

The lower band of the issue price is Rs 705 while the higher band is Rs 741.

IPO bid lot and minimum investment

A total of 2.09 crore shares are available for an upper band of Rs 741. The minimum lot size is 20, while the minimum investment at the lower end band is Rs 14,100, and the same for the upper end is Rs 14,820.

IPO Size 

The IPO is expected to fetch the company Rs. 1551 crore.
 

Offer for Sale

It's a complete offer-for-sale IPO, in which a total of 2.09 crore shares are up for grabs. 

Purpose of IPO

The company says the purpose of the IPO is to achieve the benefits of listing equity shares on stock exchanges and tocarry out the offer for the sale up to 20,925,652 equity shares by the selling shareholder.

Name of Selling Shareholder 

Helix Investment Holdings Pte. Limited is the selling shareholder.

Lead Managers

Kokak, Citi and Jefferies are the lead managers for the IPO.